Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 05, 2022 |
referred to consumer affairs and protection |
Feb 24, 2021 |
referred to consumer affairs and protection |
Assembly Bill A5721
2021-2022 Legislative Session
Sponsored By
SIMON
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
Charles Barron
Emily Gallagher
Andrew Hevesi
Judy Griffin
2021-A5721 (ACTIVE) - Details
2021-A5721 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5721 2021-2022 Regular Sessions I N A S S E M B L Y February 24, 2021 ___________ Introduced by M. of A. SIMON -- read once and referred to the Committee on Consumer Affairs and Protection AN ACT to amend the general business law, in relation to the price goug- ing of pharmaceuticals THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The general business law is amended by adding a new section 396-rrr to read as follows: § 396-RRR. PRICE GOUGING; PHARMACEUTICALS. 1. FOR THE PURPOSES OF THIS SECTION, "PHARMACEUTICALS" SHALL MEAN ANY COMPOUND MANUFACTURED FOR SALE AS A MEDICINAL DRUG. 2. NO MANUFACTURER OR WHOLESALER OF PHARMACEUTICALS SHALL SELL OR OFFER TO SELL PHARMACEUTICALS FOR AN AMOUNT WHICH REPRESENTS AN UNCON- SCIONABLY EXCESSIVE PRICE. WHETHER A PRICE IS UNCONSCIONABLY EXCESSIVE IS A QUESTION OF LAW FOR THE COURT. 3. THE COURT'S DETERMINATION THAT A VIOLATION OF THIS SECTION HAS OCCURRED SHALL BE BASED ON ANY OF THE FOLLOWING FACTORS: (A) THAT THE AMOUNT OF THE EXCESS IN PRICE IS UNCONSCIONABLY EXTREME; (B) THAT THERE WAS AN EXERCISE OF UNFAIR LEVERAGE OR UNCONSCIONABLE MEANS; OR (C) A COMBINATION OF BOTH FACTORS. 4. IN ANY COURT PROCEEDING COMMENCED PURSUANT TO THIS SECTION, PROOF THAT A VIOLATION OF THIS SECTION HAS OCCURRED SHALL INCLUDE EVIDENCE THAT: (A) THE AMOUNT CHARGED REPRESENTS A GROSS DISPARITY BETWEEN THE MARKET PRICE OF THE PHARMACEUTICAL THAT LED TO THE ACTION UNDER THIS SECTION AND THE PRICE OF THE SAME PHARMACEUTICAL OVER THE SIX MONTHS PRIOR TO THE PRICE CHANGE THAT LED TO THE ACTION UNDER THIS SECTION; OR (B) THE AMOUNT CHARGED GROSSLY EXCEEDED THE PRICE AT WHICH THE PHARMA- CEUTICALS WERE READILY OBTAINABLE BY OTHER PURCHASERS. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD09487-01-1
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.